Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Daily News

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

L.A. McKeown

March 06, 2025

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

News Daily News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

L.A. McKeown

June 29, 2022

News Daily News

Blood Clots After COVID-19 Vaccination Linked to Immune Response: UK Report

Michael O'Riordan

April 16, 2021

News Daily News

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

Todd Neale

December 22, 2020

News Daily News

Lasers Can Aid Retrieval of Stubborn IVC Filters

Caitlin E. Cox

December 02, 2020

News Daily News

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

Caitlin E. Cox

June 25, 2020

News Daily News

New AHA Guidance on Hospital VTE Stresses Risk Assessment, Standardization

Yael L. Maxwell

May 12, 2020

News Daily News

Interventional Options and Future Directions for Acute PE: New AHA Statement

Todd Neale

October 07, 2019

News Daily News

Disparities Seen in Uptake of DOACs for VTE

Todd Neale

April 05, 2019

News Daily News

Guidelines for Peripheral Interventions Often Built on Shaky Foundation

Caitlin E. Cox

January 10, 2019

News Daily News

Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF

L.A. McKeown

November 02, 2018

News Daily News

Questions Over Risk-Benefit Balance for IVC Filters Still Vex Clinicians

Caitlin E. Cox

November 17, 2016

News Daily News

Considering Pulmonary Embolism for Unexplained Syncope Is ‘Absolutely Mandatory,’ Investigators Say

Michael O'Riordan

October 24, 2016

News Daily News

Catheter-Directed Thrombolysis for DVT Increases Bleeding Compared With Standard Anticoagulation

L.A. McKeown

July 24, 2014

Advertisement

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

Blood Clots After COVID-19 Vaccination Linked to Immune Response: UK Report

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

Lasers Can Aid Retrieval of Stubborn IVC Filters

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

New AHA Guidance on Hospital VTE Stresses Risk Assessment, Standardization

Interventional Options and Future Directions for Acute PE: New AHA Statement

Disparities Seen in Uptake of DOACs for VTE

Guidelines for Peripheral Interventions Often Built on Shaky Foundation

Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF

Questions Over Risk-Benefit Balance for IVC Filters Still Vex Clinicians

Considering Pulmonary Embolism for Unexplained Syncope Is ‘Absolutely Mandatory,’ Investigators Say

Catheter-Directed Thrombolysis for DVT Increases Bleeding Compared With Standard Anticoagulation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content